Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.

Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.

Item
http://www.wikidata.org/entity/Q47977236
Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized RatsAdvances in treatment of glucocorticoid-induced osteoporosis.Role and mechanism of action of sclerostin in bone.Hormonal and systemic regulation of sclerostin.Targeting osteoblastic casein kinase-2 interacting protein-1 to enhance Smad-dependent BMP signaling and reverse bone formation reduction in glucocorticoid-induced osteoporosis.Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth.Glucocorticoids Induce Bone and Muscle Atrophy by Tissue-Specific Mechanisms Upstream of E3 Ubiquitin Ligases.PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.Sclerostin Blockade-A Dual Mode of Action After All?Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture.Cx43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice.The CRH-Transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis
P2860

Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.

Item
http://www.wikidata.org/entity/Q47977236
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@en
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@nl
type
label
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@en
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@nl
prefLabel
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@en
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Protection From Glucocorticoid ...... he Absence of Sost/Sclerostin.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921